EpiPen maker faces revolt over exec's $98 million pay package
EpiPen maker Mylan is racing to put down a revolt from shareholders outraged by a $98 million pay package for its former CEO.
Continue ReadingEpiPen maker Mylan is racing to put down a revolt from shareholders outraged by a $98 million pay package for its former CEO.
Continue Reading
Join the Discussion